{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T20:12:12Z","timestamp":1680552732107},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.leukres.2007.11.018","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T17:33:16Z","timestamp":1199295196000},"page":"689-690","source":"Crossref","is-referenced-by-count":3,"title":["Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL)"],"prefix":"10.1016","volume":"32","author":[{"given":"Silvia","family":"Buonamici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.11.018_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.leukres.2007.09.008","article-title":"Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines","volume":"32","author":"Cecchinato","year":"2008","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.leukres.2007.11.018_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-5710(95)00428-9","article-title":"Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: molecular and clinical studies employing hybrid polar compounds","volume":"63","author":"Marks","year":"1996","journal-title":"Int J Hematol"},{"issue":"22","key":"10.1016\/j.leukres.2007.11.018_bib3","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1073\/pnas.91.22.10251","article-title":"Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process","volume":"91","author":"Marks","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.leukres.2007.11.018_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0","article-title":"Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds","volume":"73","author":"Shelly","year":"1999","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.leukres.2007.11.018_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"5694","key":"10.1016\/j.leukres.2007.11.018_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.leukres.2007.11.018_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.leukres.2007.11.018_bib8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"O\u2019Neil","year":"2007","journal-title":"J Exp Med"},{"issue":"24 Pt 1","key":"10.1016\/j.leukres.2007.11.018_bib9","first-page":"7304","article-title":"Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals","volume":"48","author":"Young","year":"1988","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.leukres.2007.11.018_bib10","first-page":"3436","article-title":"Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)","volume":"49","author":"Conley","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2007.11.018_bib11","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-06-098061","article-title":"Phase I study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid SAHA) in patients with advanced leukemias and myelodysplastic syndromes","author":"Garcia-Manero","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2007.11.018_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607004614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607004614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T18:56:22Z","timestamp":1546368982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607004614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0145212607004614"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.11.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}